Thank you to our speakers, sponsors, and delegates who joined us in San Diego for the summit!
If you are interested in the 2026 event, please get in touch at [email protected]
Empower Precision Therapies with Innovative Biopsy Testing
Over the past 12 months, liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.
Cementing its position as the world’s leading forum for liquid biopsy specialists, the 9th Liquid Biopsy for Precision Oncology Summit returned to San Diego in February 2025 - with a refreshed agenda providing crucial insights spanning biomarker discovery to commercialization, and each critical step in between.
Whether you're new to the field or a seasoned expert, you could have hoined over 150 of the industry’s top decision-makers from AstraZeneca, Amgen, Eli Lilly, AbbVie, BLOODPAC, Boundless Bio, and more to ensure you and your team are equipped with the insights and connections needed to effectively integrate liquid biopsies into clinical trials and drive meaningful progress in precision oncology.
World-Class Speaker Faculty Included
Rajiv Raja
Executive Director, Precision Medicine Oncology
GSK
Valerie Mbella
Global Director
Johnson & Johnson Innovative Medicine
Anneleen Daemen
Executive Director, Translational Medicine
ORIC Pharmaceuticals
Cynthia Sandoval
Senior Director, Clinical Biomarker Development
Eli Lilly
Marielana Mata
Senior Director, Clinical Biomarkers
Vividion Therapeutics
Chris Conn
Director, Clinical
Biomarkers & Diagnostics,
Global Diagnostics
Strategy Lead
Amgen
Who Attended This Meeting?
“The Liquid Biopsy for Precision Oncology Summit is a fantastic event bringing together key stakeholders across the industry. From meeting established or new vendors and learning about the latest advances in liquid biopsy research, to reconnecting with colleagues and learning how they have overcome challenges, this meeting has always delivered.”
Peter Teriete, Senior Director & Head of Lead Discovery, IDEAYA Biosciences
2025 Partners Included
Other Events in the Series
